| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 RANBP2 RGPD8 ELMOD2 ARHGAP11A RALGAPA2 ASAP2 NF1 SYDE2 RGPD3 FLCN ARHGAP11B RGPD5 | 7.94e-08 | 279 | 139 | 13 | GO:0005096 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.73e-06 | 118 | 139 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 9.99e-06 | 20 | 139 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 RANBP2 RGPD8 ELMOD2 ARHGAP11A RALGAPA2 ASAP2 NF1 SYDE2 RGPD3 EIF2B3 FLCN ARHGAP11B RGPD5 | 1.25e-05 | 507 | 139 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 RANBP2 RGPD8 ELMOD2 ARHGAP11A RALGAPA2 ASAP2 NF1 SYDE2 RGPD3 EIF2B3 FLCN ARHGAP11B RGPD5 | 1.25e-05 | 507 | 139 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 RANBP2 RGPD8 ELMOD2 ARHGAP11A RALGAPA2 DNTTIP1 ASAP2 NF1 PLAA SYDE2 RGPD3 FLCN ARHGAP11B RGPD5 | 5.40e-05 | 656 | 139 | 15 | GO:0008047 |
| GeneOntologyMolecularFunction | microtubule binding | 6.08e-05 | 308 | 139 | 10 | GO:0008017 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.11e-04 | 36 | 139 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.28e-04 | 70 | 139 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 1.44e-04 | 3 | 139 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 1.44e-04 | 3 | 139 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | tubulin binding | WHAMM JMY TBCB NF1 KIF2B STARD9 IRAG2 CDK5RAP2 KIF2A KLC1 KIF2C | 2.07e-04 | 428 | 139 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | RARA MYO5B MYO10 EPB41L5 WHAMM PARVG JMY TBCB NF1 KIF2B STARD9 IRAG2 KCNMA1 CDK5RAP2 DAAM2 KIF2A TRAK2 KLC1 KIF2C | 2.24e-04 | 1099 | 139 | 19 | GO:0008092 |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 4.04e-04 | 50 | 139 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 4.75e-04 | 5 | 139 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 5.05e-04 | 53 | 139 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RGPD4 RANBP2 RGPD8 ELMOD2 CIP2A ARHGAP11A RALGAPA2 NLRP2 DNTTIP1 CCNG2 FRY ASAP2 NF1 PLAA SYDE2 RGPD3 EIF2B3 PPP1R37 FLCN ARHGAP11B RGPD5 | 8.08e-04 | 1418 | 139 | 21 | GO:0030234 |
| GeneOntologyMolecularFunction | small GTPase binding | 1.86e-03 | 321 | 139 | 8 | GO:0031267 | |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 4.04e-09 | 36 | 140 | 7 | GO:0035459 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.92e-07 | 20 | 140 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.50e-07 | 9 | 140 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 4.14e-07 | 10 | 140 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.39e-06 | 13 | 140 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.93e-06 | 14 | 140 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 CTAGE9 RANBP2 RGPD8 MYO5B MYO10 WHAMM CTAGE6 LYST RANBP17 CDAN1 IGF2R NF1 MDN1 MIA2 CTAGE1 RGPD3 CTAGE8 CTAGE15 KIF2A TRAK2 CTAGE4 CLEC16A DYNC1H1 KLC1 RGPD5 | 7.85e-06 | 1496 | 140 | 26 | GO:0046907 |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 1.32e-05 | 159 | 140 | 8 | GO:0006888 | |
| GeneOntologyBiologicalProcess | recombinational repair | 5.49e-05 | 194 | 140 | 8 | GO:0000725 | |
| GeneOntologyBiologicalProcess | import into nucleus | 7.04e-05 | 201 | 140 | 8 | GO:0051170 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.25e-04 | 38 | 140 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | male gamete generation | TCP11X1 TCP11X2 ZPBP CIP2A DRC1 TEX15 FANCA IGF2R MROH2B CCDC62 ASPM OSBP2 ZPBP2 ATM PIWIL3 | 2.14e-04 | 762 | 140 | 15 | GO:0048232 |
| GeneOntologyCellularComponent | SUMO ligase complex | 5.00e-09 | 21 | 145 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.47e-08 | 42 | 145 | 7 | GO:0070971 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.52e-07 | 8 | 145 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.14e-07 | 20 | 145 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 4.52e-07 | 10 | 145 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.11e-06 | 14 | 145 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | microtubule end | 6.25e-06 | 38 | 145 | 5 | GO:1990752 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 6.30e-06 | 18 | 145 | 4 | GO:0044615 | |
| GeneOntologyCellularComponent | microtubule plus-end | 3.99e-05 | 28 | 145 | 4 | GO:0035371 | |
| GeneOntologyCellularComponent | nuclear pore | 7.41e-05 | 101 | 145 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | chromosome, telomeric region | 2.32e-04 | 176 | 145 | 7 | GO:0000781 | |
| GeneOntologyCellularComponent | kinesin complex | 3.69e-04 | 49 | 145 | 4 | GO:0005871 | |
| GeneOntologyCellularComponent | inclusion body | 4.10e-04 | 90 | 145 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase complex | 4.71e-04 | 5 | 145 | 2 | GO:0070418 | |
| GeneOntologyCellularComponent | DNA repair complex | 5.23e-04 | 23 | 145 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | site of double-strand break | 6.96e-04 | 101 | 145 | 5 | GO:0035861 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | RGPD4 PIGN CTAGE9 RANBP2 FMO4 RGPD8 CYP4Z1 CTAGE6 NBAS MIA2 CTAGE1 RGPD3 CTAGE8 IRAG2 PIGW CTAGE15 TRPM8 LSS ATP11A CTAGE4 | 8.56e-04 | 1327 | 145 | 20 | GO:0042175 |
| GeneOntologyCellularComponent | microtubule associated complex | 9.16e-04 | 161 | 145 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | DNA-dependent protein kinase-DNA ligase 4 complex | 9.81e-04 | 7 | 145 | 2 | GO:0005958 | |
| GeneOntologyCellularComponent | Smc5-Smc6 complex | 1.67e-03 | 9 | 145 | 2 | GO:0030915 | |
| GeneOntologyCellularComponent | nonhomologous end joining complex | 1.67e-03 | 9 | 145 | 2 | GO:0070419 | |
| GeneOntologyCellularComponent | zona pellucida receptor complex | 2.52e-03 | 11 | 145 | 2 | GO:0002199 | |
| GeneOntologyCellularComponent | site of DNA damage | 2.69e-03 | 137 | 145 | 5 | GO:0090734 | |
| GeneOntologyCellularComponent | chromosomal region | 2.73e-03 | 421 | 145 | 9 | GO:0098687 | |
| GeneOntologyCellularComponent | centrosome | SLF1 ANKRD26 FRY KIF2B PDE4DIP ASPM IRAG2 FLCN CDK5RAP2 KIF2A ATM DYNC1H1 KIF2C | 2.77e-03 | 770 | 145 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | transferase complex | RGPD4 ZYG11A RANBP2 SLF1 RGPD8 POLE2 TRRAP FBXL4 CHUK CCNG2 SLF2 RGPD3 PRKDC PRAMEF26 XRCC6 | 2.87e-03 | 963 | 145 | 15 | GO:1990234 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 RANBP2 MMS22L RARA RGPD8 NELFCD ORC3 POLE2 DRAP1 TRRAP DNTTIP1 FANCA RANBP17 WDR3 RGPD3 PRKDC XRCC6 RGPD5 SYMPK | 3.16e-03 | 1377 | 145 | 19 | GO:0140513 |
| GeneOntologyCellularComponent | acrosomal vesicle | 3.19e-03 | 206 | 145 | 6 | GO:0001669 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 6.60e-06 | 16 | 112 | 4 | MP:0003701 | |
| MousePheno | decreased circulating VLDL triglyceride level | 1.38e-05 | 19 | 112 | 4 | MP:0003976 | |
| MousePheno | abnormal blastocyst formation | 1.40e-05 | 39 | 112 | 5 | MP:0012128 | |
| MousePheno | increased organ/body region tumor incidence | RGPD4 RANBP2 RGPD8 RALGAPA2 CHUK NF1 RGPD3 FLCN CDK5RAP2 ATP11A PRKDC ATM XRCC6 | 1.62e-05 | 395 | 112 | 13 | MP:0010274 |
| MousePheno | abnormal organ/body region tumor incidence | RGPD4 RANBP2 RGPD8 RALGAPA2 CHUK NF1 RGPD3 FLCN CDK5RAP2 ATP11A PRKDC ATM XRCC6 | 1.90e-05 | 401 | 112 | 13 | MP:0013152 |
| MousePheno | increased tumor incidence | RGPD4 RANBP2 RGPD8 RALGAPA2 LYST CHUK TTC7A NF1 RGPD3 FLCN CDK5RAP2 ATP11A PRKDC ATM XRCC6 | 2.08e-05 | 530 | 112 | 15 | MP:0002020 |
| MousePheno | abnormal tumor incidence | RGPD4 RANBP2 RGPD8 RALGAPA2 LYST CHUK TTC7A NF1 RGPD3 FLCN CDK5RAP2 ATP11A PRKDC ATM IL1R1 XRCC6 | 4.45e-05 | 635 | 112 | 16 | MP:0002019 |
| MousePheno | abnormal morula morphology | 5.10e-05 | 26 | 112 | 4 | MP:0012058 | |
| MousePheno | increased classified tumor incidence | RGPD4 RANBP2 RGPD8 CHUK TTC7A NF1 RGPD3 FLCN CDK5RAP2 PRKDC ATM XRCC6 | 5.37e-05 | 381 | 112 | 12 | MP:0010273 |
| MousePheno | abnormal classified tumor incidence | RGPD4 RANBP2 RGPD8 CHUK TTC7A NF1 RGPD3 FLCN CDK5RAP2 PRKDC ATM XRCC6 | 5.79e-05 | 384 | 112 | 12 | MP:0020188 |
| MousePheno | abnormal tumor susceptibility | RGPD4 RANBP2 RGPD8 RALGAPA2 LYST CHUK TTC7A NF1 RGPD3 FLCN CDK5RAP2 ATP11A PRKDC ATM IL1R1 XRCC6 | 5.88e-05 | 650 | 112 | 16 | MP:0002166 |
| MousePheno | abnormal mitosis | 7.48e-05 | 128 | 112 | 7 | MP:0004046 | |
| MousePheno | decreased tumor latency | 9.11e-05 | 30 | 112 | 4 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 1.04e-04 | 31 | 112 | 4 | MP:0012129 | |
| MousePheno | abnormal cell nucleus morphology | 1.15e-04 | 184 | 112 | 8 | MP:0003111 | |
| MousePheno | abnormal tumor latency | 1.50e-04 | 34 | 112 | 4 | MP:0010307 | |
| MousePheno | increased sarcoma incidence | 1.67e-04 | 102 | 112 | 6 | MP:0002032 | |
| MousePheno | increased respiratory system tumor incidence | 2.17e-04 | 107 | 112 | 6 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 2.17e-04 | 107 | 112 | 6 | MP:0008014 | |
| MousePheno | increased hepatocellular carcinoma incidence | 2.41e-04 | 70 | 112 | 5 | MP:0003331 | |
| MousePheno | abnormal tail pigmentation | 2.59e-04 | 39 | 112 | 4 | MP:0005174 | |
| MousePheno | increased hepatobiliary system tumor incidence | 2.65e-04 | 111 | 112 | 6 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 2.65e-04 | 111 | 112 | 6 | MP:0008019 | |
| MousePheno | neoplasm | RGPD4 RANBP2 RGPD8 RALGAPA2 LYST CHUK TTC7A NF1 RGPD3 FLCN CDK5RAP2 ATP11A PRKDC ATM IL1R1 XRCC6 | 2.92e-04 | 747 | 112 | 16 | MP:0002006 |
| MousePheno | abnormal embryonic/fetal subventricular zone morphology | 3.15e-04 | 41 | 112 | 4 | MP:0004274 | |
| MousePheno | increased lung carcinoma incidence | 4.00e-04 | 78 | 112 | 5 | MP:0008714 | |
| MousePheno | increased incidence of induced tumors | 4.79e-04 | 173 | 112 | 7 | MP:0002021 | |
| MousePheno | abnormal chromosome morphology | 5.22e-04 | 126 | 112 | 6 | MP:0003702 | |
| MousePheno | abnormal neocortex morphology | 5.79e-04 | 48 | 112 | 4 | MP:0008547 | |
| Domain | ARM-type_fold | ZYG11A CIP2A TTI2 RALGAPA2 TRRAP LYST PAIP1 RANBP17 NF1 PLAA MROH2B EIF4G1 ASPM DAAM2 PRKDC ATM BRAT1 ARMH3 SYMPK | 4.24e-12 | 339 | 134 | 19 | IPR016024 |
| Domain | TPR-contain_dom | RGPD4 RANBP2 RGPD8 TTC7A TMTC3 SH3TC1 RGPD3 PRKDC EDRF1 KLC1 RGPD5 | 1.09e-08 | 150 | 134 | 11 | IPR013026 |
| Domain | Ran_BP1 | 1.34e-08 | 12 | 134 | 5 | PF00638 | |
| Domain | RANBD1 | 1.34e-08 | 12 | 134 | 5 | PS50196 | |
| Domain | RanBD | 2.17e-08 | 13 | 134 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 2.17e-08 | 13 | 134 | 5 | IPR000156 | |
| Domain | TPR_REGION | RGPD4 RANBP2 RGPD8 TTC7A TMTC3 SH3TC1 RGPD3 PRKDC EDRF1 KLC1 RGPD5 | 2.95e-08 | 165 | 134 | 11 | PS50293 |
| Domain | TPR | RGPD4 RANBP2 RGPD8 TTC7A TMTC3 SH3TC1 RGPD3 PRKDC EDRF1 KLC1 RGPD5 | 2.95e-08 | 165 | 134 | 11 | PS50005 |
| Domain | ARM-like | ZYG11A CIP2A TTI2 TRRAP RANBP17 NF1 PLAA MROH2B ASPM DAAM2 PRKDC BRAT1 SYMPK | 7.53e-08 | 270 | 134 | 13 | IPR011989 |
| Domain | TPR-like_helical_dom | RGPD4 RANBP2 RGPD8 TRRAP TTC7A TMTC3 SH3TC1 RGPD3 PRKDC EDRF1 KLC1 RGPD5 | 1.18e-07 | 233 | 134 | 12 | IPR011990 |
| Domain | - | ZYG11A CIP2A TRRAP RANBP17 NF1 MROH2B ASPM DAAM2 PRKDC BRAT1 SYMPK | 5.97e-07 | 222 | 134 | 11 | 1.25.10.10 |
| Domain | Grip | 8.04e-07 | 11 | 134 | 4 | SM00755 | |
| Domain | GRIP | 8.04e-07 | 11 | 134 | 4 | PF01465 | |
| Domain | GRIP_dom | 1.20e-06 | 12 | 134 | 4 | IPR000237 | |
| Domain | GRIP | 1.20e-06 | 12 | 134 | 4 | PS50913 | |
| Domain | - | RGPD4 RANBP2 RGPD8 TRRAP TTC7A TMTC3 SH3TC1 RGPD3 EDRF1 KLC1 | 2.49e-06 | 207 | 134 | 10 | 1.25.40.10 |
| Domain | TPR_1 | 3.81e-06 | 90 | 134 | 7 | IPR001440 | |
| Domain | TPR_1 | 3.81e-06 | 90 | 134 | 7 | PF00515 | |
| Domain | TPR | 4.19e-06 | 129 | 134 | 8 | SM00028 | |
| Domain | TPR_repeat | 5.26e-06 | 133 | 134 | 8 | IPR019734 | |
| Domain | FAT | 7.11e-06 | 6 | 134 | 3 | PS51189 | |
| Domain | FATC | 7.11e-06 | 6 | 134 | 3 | PS51190 | |
| Domain | FAT | 7.11e-06 | 6 | 134 | 3 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 7.11e-06 | 6 | 134 | 3 | IPR003151 | |
| Domain | FATC_dom | 7.11e-06 | 6 | 134 | 3 | IPR003152 | |
| Domain | PIK_FAT | 7.11e-06 | 6 | 134 | 3 | IPR014009 | |
| Domain | FATC | 7.11e-06 | 6 | 134 | 3 | SM01343 | |
| Domain | PH_dom-like | RGPD4 RANBP2 RGPD8 MYO10 FRMPD1 EPB41L5 LYST AFAP1L1 FRMD4A ASAP2 RGPD3 OSBP2 RGPD5 | 1.22e-05 | 426 | 134 | 13 | IPR011993 |
| Domain | Rab_bind | 1.24e-05 | 7 | 134 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.24e-05 | 7 | 134 | 3 | IPR032023 | |
| Domain | - | 4.18e-05 | 10 | 134 | 3 | 1.10.220.60 | |
| Domain | WHAMM-JMY_N | 5.11e-05 | 2 | 134 | 2 | PF15920 | |
| Domain | Methyltransf_2 | 5.11e-05 | 2 | 134 | 2 | PF00891 | |
| Domain | Sp38-bd | 5.11e-05 | 2 | 134 | 2 | IPR010857 | |
| Domain | JMY/WHAMM | 5.11e-05 | 2 | 134 | 2 | IPR031738 | |
| Domain | O_MeTrfase_2 | 5.11e-05 | 2 | 134 | 2 | IPR001077 | |
| Domain | ASMT_dimerisation | 5.11e-05 | 2 | 134 | 2 | IPR031725 | |
| Domain | JMY | 5.11e-05 | 2 | 134 | 2 | PF15871 | |
| Domain | SAM_OMT_II | 5.11e-05 | 2 | 134 | 2 | PS51683 | |
| Domain | Sp38 | 5.11e-05 | 2 | 134 | 2 | PF07354 | |
| Domain | O-MeTrfase_COMT | 5.11e-05 | 2 | 134 | 2 | IPR016461 | |
| Domain | Dimerisation2 | 5.11e-05 | 2 | 134 | 2 | PF16864 | |
| Domain | JMY/WHAMM_N | 5.11e-05 | 2 | 134 | 2 | IPR031808 | |
| Domain | Cnn_1N | 1.53e-04 | 3 | 134 | 2 | IPR012943 | |
| Domain | Cnn_1N | 1.53e-04 | 3 | 134 | 2 | PF07989 | |
| Domain | - | 1.89e-04 | 16 | 134 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.89e-04 | 16 | 134 | 3 | SM00146 | |
| Domain | Kinesin_motor_CS | 2.09e-04 | 41 | 134 | 4 | IPR019821 | |
| Domain | PI3_PI4_kinase | 2.72e-04 | 18 | 134 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 2.72e-04 | 18 | 134 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.72e-04 | 18 | 134 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 2.72e-04 | 18 | 134 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 2.72e-04 | 18 | 134 | 3 | PS50290 | |
| Domain | - | 2.75e-04 | 44 | 134 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 2.75e-04 | 44 | 134 | 4 | PF00225 | |
| Domain | KISc | 2.75e-04 | 44 | 134 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 2.75e-04 | 44 | 134 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 2.75e-04 | 44 | 134 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.75e-04 | 44 | 134 | 4 | PS50067 | |
| Domain | Retinoic_acid_rcpt | 3.04e-04 | 4 | 134 | 2 | IPR003078 | |
| Domain | FERM_M | 3.27e-04 | 46 | 134 | 4 | PF00373 | |
| Domain | - | 4.18e-04 | 49 | 134 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 4.18e-04 | 49 | 134 | 4 | IPR019748 | |
| Domain | FERM_domain | 4.18e-04 | 49 | 134 | 4 | IPR000299 | |
| Domain | Rho_GTPase_activation_prot | 4.29e-04 | 88 | 134 | 5 | IPR008936 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 4.52e-04 | 50 | 134 | 4 | IPR014352 | |
| Domain | FERM_1 | 4.52e-04 | 50 | 134 | 4 | PS00660 | |
| Domain | FERM_2 | 4.52e-04 | 50 | 134 | 4 | PS00661 | |
| Domain | FERM_3 | 4.52e-04 | 50 | 134 | 4 | PS50057 | |
| Domain | Band_41_domain | 4.52e-04 | 50 | 134 | 4 | IPR019749 | |
| Domain | B41 | 4.52e-04 | 50 | 134 | 4 | SM00295 | |
| Domain | FATC | 5.04e-04 | 5 | 134 | 2 | PF02260 | |
| Domain | - | RGPD4 RANBP2 RGPD8 MYO10 EPB41L5 AFAP1L1 FRMD4A ASAP2 RGPD3 OSBP2 | 5.26e-04 | 391 | 134 | 10 | 2.30.29.30 |
| Domain | CPSASE_2 | 7.52e-04 | 6 | 134 | 2 | PS00867 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 1.05e-03 | 7 | 134 | 2 | IPR005479 | |
| Domain | BC-like_N | 1.05e-03 | 7 | 134 | 2 | IPR005481 | |
| Domain | CPSase_L_D2 | 1.05e-03 | 7 | 134 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 1.05e-03 | 7 | 134 | 2 | PF00289 | |
| Domain | PIWI | 1.39e-03 | 8 | 134 | 2 | PS50822 | |
| Domain | Piwi | 1.39e-03 | 8 | 134 | 2 | SM00950 | |
| Domain | Piwi | 1.39e-03 | 8 | 134 | 2 | PF02171 | |
| Domain | Piwi | 1.39e-03 | 8 | 134 | 2 | IPR003165 | |
| Domain | FERM_N | 1.68e-03 | 33 | 134 | 3 | IPR018979 | |
| Domain | FERM_N | 1.68e-03 | 33 | 134 | 3 | PF09379 | |
| Domain | PAZ | 1.78e-03 | 9 | 134 | 2 | PS50821 | |
| Domain | PAZ | 1.78e-03 | 9 | 134 | 2 | SM00949 | |
| Domain | PAZ | 1.78e-03 | 9 | 134 | 2 | PF02170 | |
| Domain | PAZ_dom | 1.78e-03 | 9 | 134 | 2 | IPR003100 | |
| Domain | MIF4G | 2.21e-03 | 10 | 134 | 2 | SM00543 | |
| Domain | MIF4G | 2.21e-03 | 10 | 134 | 2 | PF02854 | |
| Domain | MIF4G-like_typ-3 | 2.21e-03 | 10 | 134 | 2 | IPR003890 | |
| Domain | Kinesin-like_fam | 3.61e-03 | 43 | 134 | 3 | IPR027640 | |
| Domain | - | 3.78e-03 | 13 | 134 | 2 | 3.40.50.20 | |
| Domain | ATPase_dyneun-rel_AAA | 4.39e-03 | 14 | 134 | 2 | IPR011704 | |
| Domain | ATP_GRASP | 4.39e-03 | 14 | 134 | 2 | PS50975 | |
| Domain | ATP-grasp | 4.39e-03 | 14 | 134 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 4.39e-03 | 14 | 134 | 2 | IPR016185 | |
| Domain | AAA_5 | 4.39e-03 | 14 | 134 | 2 | PF07728 | |
| Domain | HEAT | 4.93e-03 | 48 | 134 | 3 | PF02985 | |
| Domain | - | 5.05e-03 | 15 | 134 | 2 | 1.25.40.180 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 5.67e-07 | 100 | 101 | 8 | MM14561 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.88e-06 | 117 | 101 | 8 | MM15387 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.92e-06 | 129 | 101 | 8 | MM14894 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 7.03e-06 | 18 | 101 | 4 | MM1549 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.58e-06 | 141 | 101 | 8 | MM15266 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RANBP2 RGPD8 ANKRD26 WHAMM ARHGAP11A KIF2B SYDE2 RGPD3 KIF2A TRAK2 ARHGAP11B PLXNA1 DYNC1H1 KLC1 KIF2C | 1.41e-05 | 649 | 101 | 16 | MM15690 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.43e-05 | 202 | 101 | 9 | MM15362 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 2.41e-05 | 271 | 101 | 10 | MM15388 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.54e-05 | 49 | 101 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.80e-05 | 50 | 101 | 5 | MM14610 | |
| Pathway | PID_BARD1_PATHWAY | 5.14e-05 | 29 | 101 | 4 | M258 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 7.28e-05 | 193 | 101 | 8 | MM14890 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 9.37e-05 | 257 | 101 | 9 | MM14755 | |
| Pathway | REACTOME_CARGO_CONCENTRATION_IN_THE_ER | 1.23e-04 | 36 | 101 | 4 | MM15300 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.86e-04 | 40 | 101 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.05e-04 | 41 | 101 | 4 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.25e-04 | 42 | 101 | 4 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.47e-04 | 43 | 101 | 4 | MM14609 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 2.74e-04 | 234 | 101 | 8 | MM14898 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 3.49e-04 | 47 | 101 | 4 | MM14939 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 3.54e-04 | 131 | 101 | 6 | MM15497 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 RANBP2 RGPD8 ORC3 POLE2 SHQ1 KIF2B RGPD3 CDK5RAP2 KIF2A ATM DYNC1H1 KIF2C | 3.62e-04 | 603 | 101 | 13 | MM14635 |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 3.76e-04 | 86 | 101 | 5 | MM15413 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 3.99e-04 | 134 | 101 | 6 | M27751 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 4.14e-04 | 189 | 101 | 7 | MM15356 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 4.79e-04 | 51 | 101 | 4 | MM15151 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 6.35e-04 | 203 | 101 | 7 | M27654 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 6.40e-04 | 55 | 101 | 4 | MM14917 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 6.85e-04 | 98 | 101 | 5 | MM15352 | |
| Pathway | REACTOME_KINESINS | 7.33e-04 | 57 | 101 | 4 | MM15714 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 7.48e-04 | 6 | 101 | 2 | M48097 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 7.51e-04 | 100 | 101 | 5 | M27650 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 7.83e-04 | 58 | 101 | 4 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 7.83e-04 | 58 | 101 | 4 | MM14736 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 9.47e-04 | 61 | 101 | 4 | MM15912 | |
| Pathway | REACTOME_KINESINS | 9.47e-04 | 61 | 101 | 4 | M977 | |
| Pathway | WP_NONHOMOLOGOUS_END_JOINING | 1.04e-03 | 7 | 101 | 2 | MM15989 | |
| Pathway | WP_G1_TO_S_CELL_CYCLE_CONTROL | 1.13e-03 | 64 | 101 | 4 | M39627 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 1.20e-03 | 111 | 101 | 5 | M27673 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.20e-03 | 65 | 101 | 4 | MM15147 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.46e-03 | 116 | 101 | 5 | MM14855 | |
| Pubmed | RGPD4 RANBP2 RGPD8 MYO5B NELFCD ANKRD26 CTAGE6 FAM98B LYST CHUK TBCB MDN1 MIA2 SACS STARD9 CTAGE1 RGPD3 CTAGE8 EIF4G1 ASPM CTAGE15 SPDEF ATP11A PRKDC ATM CTAGE4 IL1R1 XRCC6 RGPD5 | 1.92e-12 | 1442 | 146 | 29 | 35575683 | |
| Pubmed | Mea6 controls VLDL transport through the coordinated regulation of COPII assembly. | 2.98e-10 | 4 | 146 | 4 | 27311593 | |
| Pubmed | Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance. | 2.98e-10 | 4 | 146 | 4 | 33718348 | |
| Pubmed | 2.98e-10 | 4 | 146 | 4 | 12586826 | ||
| Pubmed | 2.98e-10 | 4 | 146 | 4 | 31244610 | ||
| Pubmed | 2.98e-10 | 4 | 146 | 4 | 21807889 | ||
| Pubmed | SHLD2 MMS22L SLF1 ORC3 CIP2A FAM98B DNTTIP1 FANCA MDN1 SLF2 MAIP1 KIF2A ATM XRCC6 KIF2C | 9.37e-10 | 453 | 146 | 15 | 29656893 | |
| Pubmed | 1.49e-09 | 5 | 146 | 4 | 19131326 | ||
| Pubmed | cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. | 1.49e-09 | 5 | 146 | 4 | 12839582 | |
| Pubmed | 1.49e-09 | 5 | 146 | 4 | 18630941 | ||
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 1.49e-09 | 5 | 146 | 4 | 15183315 | |
| Pubmed | Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development. | 1.49e-09 | 5 | 146 | 4 | 38439956 | |
| Pubmed | A tissue-specific atlas of mouse protein phosphorylation and expression. | 1.49e-09 | 5 | 146 | 4 | 21183079 | |
| Pubmed | PIGN RANBP2 CAD ELMOD2 NELFCD ADCY3 NBAS IGF2R NF1 MDN1 MIA2 EIF4G1 IRAG2 LSS ATP11A KIF2A PRKDC BRAT1 DYNC1H1 XRCC6 KLC1 KIF2C | 4.09e-09 | 1168 | 146 | 22 | 19946888 | |
| Pubmed | RGPD4 RANBP2 CAD RGPD8 HECW1 FRY IGF2R NF1 AGO1 MDN1 RGPD3 PDE4DIP EIF4G1 KCNMA1 CDK5RAP2 KIF2A DYNC1H1 XRCC6 KLC1 KIF2C | 4.39e-09 | 963 | 146 | 20 | 28671696 | |
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.03e-08 | 7 | 146 | 4 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.03e-08 | 7 | 146 | 4 | 11353387 | |
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 30944974 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.03e-08 | 7 | 146 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.03e-08 | 7 | 146 | 4 | 17372272 | |
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 38657106 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 21205196 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 18949001 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 25187515 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 8603673 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 26632511 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 24403063 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 23818861 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 29133483 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 23536549 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 12191015 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 22821000 | ||
| Pubmed | 1.03e-08 | 7 | 146 | 4 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 2.06e-08 | 8 | 146 | 4 | 21670213 | |
| Pubmed | 2.06e-08 | 8 | 146 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 2.06e-08 | 8 | 146 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 2.06e-08 | 8 | 146 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 2.06e-08 | 8 | 146 | 4 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 3.69e-08 | 9 | 146 | 4 | 18394993 | |
| Pubmed | Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. | 3.69e-08 | 9 | 146 | 4 | 18342301 | |
| Pubmed | 3.69e-08 | 9 | 146 | 4 | 28100513 | ||
| Pubmed | 3.69e-08 | 9 | 146 | 4 | 17887960 | ||
| Pubmed | 3.69e-08 | 9 | 146 | 4 | 11553612 | ||
| Pubmed | 3.69e-08 | 9 | 146 | 4 | 10601307 | ||
| Pubmed | 3.69e-08 | 9 | 146 | 4 | 9733766 | ||
| Pubmed | 3.69e-08 | 9 | 146 | 4 | 28877029 | ||
| Pubmed | 6.14e-08 | 10 | 146 | 4 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 6.14e-08 | 10 | 146 | 4 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 6.14e-08 | 10 | 146 | 4 | 8857542 | |
| Pubmed | 6.14e-08 | 10 | 146 | 4 | 21859863 | ||
| Pubmed | 7.25e-08 | 3 | 146 | 3 | 17538014 | ||
| Pubmed | 9.61e-08 | 11 | 146 | 4 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 9.61e-08 | 11 | 146 | 4 | 35771867 | |
| Pubmed | 9.61e-08 | 11 | 146 | 4 | 34110283 | ||
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 2.07e-07 | 13 | 146 | 4 | 11839810 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.07e-07 | 13 | 146 | 4 | 31427429 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 CAD SPR EPB41L5 EXOC3 MCCC1 TRRAP TBCB WDR3 NF1 MDN1 PLAA EIF2B3 EIF4G1 ASPM PPP1R37 KIF2A PRKDC DYNC1H1 XRCC6 KIF2C | 2.49e-07 | 1353 | 146 | 21 | 29467282 |
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 11158303 | ||
| Pubmed | Functional interaction of BRCA1/ATM-associated BAAT1 with the DNA-PK catalytic subunit. | 2.89e-07 | 4 | 146 | 3 | 22977523 | |
| Pubmed | 2.89e-07 | 4 | 146 | 3 | 9480752 | ||
| Pubmed | 3.46e-07 | 215 | 146 | 9 | 35973513 | ||
| Pubmed | cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development. | 3.92e-07 | 15 | 146 | 4 | 30224460 | |
| Pubmed | 3.92e-07 | 15 | 146 | 4 | 14697343 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 RANBP2 CAD RGPD8 ORC3 FAM98B WDR3 RGPD3 EIF4G1 ATM DYNC1H1 | 5.18e-07 | 370 | 146 | 11 | 22922362 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RANBP2 NELFCD ORC3 FRMPD1 DRAP1 TRRAP CHUK DNTTIP1 TBC1D32 MDN1 SH3TC1 ASMTL EIF4G1 DYNC1H1 KIF2C SYMPK | 7.09e-07 | 857 | 146 | 16 | 25609649 |
| Pubmed | 7.20e-07 | 5 | 146 | 3 | 11248063 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NELFCD ANKRD26 EPB41L5 MCCC1 LYST NF1 MDN1 SLF2 STARD9 SYDE2 EIF4G1 CCDC138 KIF2A EDRF1 KLC1 KIF2C | 7.54e-07 | 861 | 146 | 16 | 36931259 |
| Pubmed | 8.47e-07 | 76 | 146 | 6 | 27542412 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO10 RALGAPA2 ZZEF1 TRRAP LYST FANCA IGF2R MDN1 SH3TC1 EIF2B3 EIF4G1 PIGW FLCN PRKDC BRAT1 PLXNA1 DYNC1H1 SYMPK | 9.81e-07 | 1105 | 146 | 18 | 35748872 |
| Pubmed | 1.44e-06 | 6 | 146 | 3 | 14966265 | ||
| Pubmed | DNA-PK suppresses a p53-independent apoptotic response to DNA damage. | 1.44e-06 | 6 | 146 | 3 | 19057578 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.54e-06 | 332 | 146 | 10 | 32786267 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RANBP2 RGPD8 ORC3 EXOC3 TF NBAS PLAA RGPD3 EIF4G1 ASPM CDK5RAP2 MAIP1 PRKDC ATM DYNC1H1 XRCC6 RGPD5 | 1.83e-06 | 1155 | 146 | 18 | 20360068 |
| Pubmed | 2.06e-06 | 22 | 146 | 4 | 27717094 | ||
| Pubmed | 2.51e-06 | 7 | 146 | 3 | 27829214 | ||
| Pubmed | 2.51e-06 | 7 | 146 | 3 | 25818648 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TTI2 ARHGAP11A PARVG ZZEF1 FANCA FRY MDN1 SYDE2 PIGW PRKDC ATM DYNC1H1 XRCC6 SYMPK | 2.95e-06 | 736 | 146 | 14 | 29676528 |
| Pubmed | 3.19e-06 | 210 | 146 | 8 | 16565220 | ||
| Pubmed | 4.00e-06 | 8 | 146 | 3 | 28345663 | ||
| Pubmed | 4.00e-06 | 8 | 146 | 3 | 10823961 | ||
| Pubmed | 4.00e-06 | 8 | 146 | 3 | 20810650 | ||
| Pubmed | TTBK2 with EB1/3 regulates microtubule dynamics in migrating cells through KIF2A phosphorylation. | 4.00e-06 | 8 | 146 | 3 | 26323690 | |
| Pubmed | 4.01e-06 | 99 | 146 | 6 | 27746211 | ||
| Pubmed | RANBP2 CAD TRRAP WDR3 IGF2R NF1 MDN1 EIF4G1 PRKDC ATM DYNC1H1 XRCC6 SYMPK | 4.15e-06 | 653 | 146 | 13 | 22586326 | |
| Pubmed | CAD CIP2A POLE2 ANKRD26 EPB41L5 EXOC3 WDR3 NBAS IGF2R MDN1 TMTC3 SACS CCDC138 ASPM CDK5RAP2 LSS ATM EDRF1 XRCC6 KLC1 | 4.39e-06 | 1487 | 146 | 20 | 33957083 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MMS22L IDO1 MYO10 ORC3 MAB21L4 SETD4 TRRAP WDR3 NF1 AGO1 MDN1 ASPM IRAG2 CDK5RAP2 DAAM2 ATP11A ARMH3 SYMPK | 5.02e-06 | 1242 | 146 | 18 | 30973865 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 5.34e-06 | 104 | 146 | 6 | 31240132 | |
| Pubmed | 5.98e-06 | 9 | 146 | 3 | 24657168 | ||
| Pubmed | Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. | 5.98e-06 | 9 | 146 | 3 | 16413926 | |
| Pubmed | RARB WHAMM TF CHUK WDR3 FRY MIA2 SACS SLF2 PDE4DIP EIF4G1 FIBP DAAM2 ANKRD36 PRKDC ATM DYNC1H1 XRCC6 | 7.97e-06 | 1285 | 146 | 18 | 35914814 | |
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 8.51e-06 | 10 | 146 | 3 | 18160036 | |
| Pubmed | MYO10 FRMPD1 ADCY3 STARD9 PDE4DIP PACS2 DAAM2 TRAK2 CLEC16A DYNC1H1 | 9.30e-06 | 407 | 146 | 10 | 12693553 | |
| Pubmed | RANBP2 CAD CIP2A TTI2 FAM98B MCCC1 ARHGAP11A JMY CHUK WDR3 NBAS MDN1 EIF2B3 EIF4G1 MAIP1 PRKDC ATM DYNC1H1 XRCC6 | 1.02e-05 | 1440 | 146 | 19 | 30833792 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 1.17e-05 | 11 | 146 | 3 | 20427287 | |
| Pubmed | 1.17e-05 | 11 | 146 | 3 | 16354686 | ||
| Pubmed | Eml1 loss impairs apical progenitor spindle length and soma shape in the developing cerebral cortex. | 1.17e-05 | 11 | 146 | 3 | 29229923 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RGPD4 RANBP2 CAD RGPD8 DRAP1 RGPD3 EIF4G1 KIF2A PRKDC DYNC1H1 XRCC6 RGPD5 | 1.43e-05 | 626 | 146 | 12 | 33644029 |
| Pubmed | MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining. | 1.55e-05 | 12 | 146 | 3 | 30017584 | |
| Interaction | CTAGE1 interactions | 1.98e-11 | 10 | 139 | 6 | int:CTAGE1 | |
| Interaction | RGPD2 interactions | 2.54e-08 | 27 | 139 | 6 | int:RGPD2 | |
| Interaction | GPR17 interactions | MMS22L CIP2A TTI2 EXOC3 FANCA NBAS MDN1 PLAA SACS EIF2B3 PRKDC ATM BRAT1 | 8.43e-08 | 283 | 139 | 13 | int:GPR17 |
| Interaction | MIA2 interactions | 8.85e-08 | 113 | 139 | 9 | int:MIA2 | |
| Interaction | CTAGE4 interactions | 3.21e-07 | 3 | 139 | 3 | int:CTAGE4 | |
| Interaction | RGPD4 interactions | 3.48e-07 | 22 | 139 | 5 | int:RGPD4 | |
| Interaction | RGPD3 interactions | 8.22e-07 | 47 | 139 | 6 | int:RGPD3 | |
| Interaction | C3orf18 interactions | 1.33e-06 | 115 | 139 | 8 | int:C3orf18 | |
| Interaction | CTAGE15 interactions | 3.18e-06 | 5 | 139 | 3 | int:CTAGE15 | |
| Interaction | RGPD5 interactions | 4.56e-06 | 96 | 139 | 7 | int:RGPD5 | |
| Interaction | CTAGE6 interactions | 6.33e-06 | 6 | 139 | 3 | int:CTAGE6 | |
| Interaction | CTAGE8 interactions | 6.33e-06 | 6 | 139 | 3 | int:CTAGE8 | |
| Interaction | FPR1 interactions | 8.33e-06 | 147 | 139 | 8 | int:FPR1 | |
| Interaction | KLC3 interactions | 1.12e-05 | 110 | 139 | 7 | int:KLC3 | |
| Interaction | RGPD8 interactions | 1.22e-05 | 74 | 139 | 6 | int:RGPD8 | |
| Interaction | HCST interactions | 1.28e-05 | 205 | 139 | 9 | int:HCST | |
| Interaction | UBXN6 interactions | RGPD8 NLRP2 CHUK FANCA MDN1 PLAA PRKDC BRAT1 EDRF1 RGPD5 SYMPK | 1.62e-05 | 325 | 139 | 11 | int:UBXN6 |
| Interaction | TNFSF13B interactions | 1.88e-05 | 119 | 139 | 7 | int:TNFSF13B | |
| Interaction | ATOH1 interactions | 1.91e-05 | 80 | 139 | 6 | int:ATOH1 | |
| Interaction | RGPD1 interactions | 2.17e-05 | 49 | 139 | 5 | int:RGPD1 | |
| Interaction | AVPR2 interactions | 2.33e-05 | 123 | 139 | 7 | int:AVPR2 | |
| Interaction | NPTN interactions | MMS22L CIP2A TTI2 FANCA RANBP17 ANKRD44 MDN1 ATM BRAT1 SYMPK | 2.37e-05 | 278 | 139 | 10 | int:NPTN |
| Interaction | TACSTD2 interactions | 3.17e-05 | 129 | 139 | 7 | int:TACSTD2 | |
| Interaction | DNAJC7 interactions | CAD POLE2 TRRAP NF1 MDN1 SACS CDK5RAP2 LSS PRKDC ATM CLEC16A EDRF1 | 3.96e-05 | 425 | 139 | 12 | int:DNAJC7 |
| Interaction | EFNA4 interactions | 4.30e-05 | 239 | 139 | 9 | int:EFNA4 | |
| Interaction | YWHAG interactions | CAD RARA NELFCD ANKRD26 EPB41L5 TRRAP LYST AFAP1L1 FRMD4A NF1 MDN1 STARD9 SYDE2 EIF4G1 KCNMA1 PACS2 KIF2A PRKDC EDRF1 DYNC1H1 KLC1 KIF2C | 4.43e-05 | 1248 | 139 | 22 | int:YWHAG |
| Interaction | MAPRE1 interactions | RANBP2 MYO10 POLE2 ANKRD26 TBCB PDE4DIP EIF4G1 CCDC138 CDK5RAP2 KIF2A DYNC1H1 KIF2C RGPD5 | 5.80e-05 | 514 | 139 | 13 | int:MAPRE1 |
| Interaction | TSNAX interactions | 6.13e-05 | 194 | 139 | 8 | int:TSNAX | |
| Interaction | YWHAH interactions | NELFCD ANKRD26 EPB41L5 LYST TBCB FRMD4A NF1 SLF2 STARD9 SYDE2 EIF4G1 CCDC138 KCNMA1 FLCN PACS2 KIF2A CLEC16A EDRF1 KLC1 KIF2C | 6.88e-05 | 1102 | 139 | 20 | int:YWHAH |
| Interaction | GPR182 interactions | MMS22L ORC3 CIP2A TTI2 EXOC3 FANCA MDN1 CCDC138 PRKDC ATM BRAT1 SYMPK | 7.60e-05 | 455 | 139 | 12 | int:GPR182 |
| Interaction | NPY2R interactions | 9.26e-05 | 66 | 139 | 5 | int:NPY2R | |
| Interaction | MLNR interactions | 1.07e-04 | 68 | 139 | 5 | int:MLNR | |
| Interaction | SIRT6 interactions | RANBP2 CAD RGPD8 ORC3 TRRAP NLRP2 FANCA WDR3 NF1 KIF2A PRKDC XRCC6 RGPD5 SYMPK | 1.15e-04 | 628 | 139 | 14 | int:SIRT6 |
| Interaction | EDNRB interactions | 1.48e-04 | 39 | 139 | 4 | int:EDNRB | |
| Interaction | NHEJ1 interactions | 2.03e-04 | 17 | 139 | 3 | int:NHEJ1 | |
| Interaction | ZUP1 interactions | 2.08e-04 | 174 | 139 | 7 | int:ZUP1 | |
| Interaction | GYPA interactions | 2.08e-04 | 174 | 139 | 7 | int:GYPA | |
| Interaction | CD80 interactions | 2.17e-04 | 79 | 139 | 5 | int:CD80 | |
| Interaction | EEF1AKMT3 interactions | 2.21e-04 | 364 | 139 | 10 | int:EEF1AKMT3 | |
| Interaction | ANAPC2 interactions | 2.24e-04 | 234 | 139 | 8 | int:ANAPC2 | |
| Interaction | DNAI2 interactions | 2.31e-04 | 80 | 139 | 5 | int:DNAI2 | |
| Interaction | RICTOR interactions | RGPD4 CAD RGPD8 CIP2A CHUK TBCB IGF2R LRRC31 RGPD3 EIF4G1 PRKDC CLEC16A DYNC1H1 XRCC6 RGPD5 | 2.43e-04 | 759 | 139 | 15 | int:RICTOR |
| Interaction | NPIPB6 interactions | 2.43e-04 | 18 | 139 | 3 | int:NPIPB6 | |
| Interaction | PARP1 interactions | RARA RARB MYO5B ORC3 CIP2A TRRAP NLRP2 DNTTIP1 WDR3 ASAP2 MDN1 SACS LRRC31 STARD9 CDK5RAP2 KIF2A PRKDC ATM BRAT1 PIWIL3 XRCC6 | 2.69e-04 | 1316 | 139 | 21 | int:PARP1 |
| Interaction | LGSN interactions | 2.81e-04 | 4 | 139 | 2 | int:LGSN | |
| Interaction | NPAS1 interactions | 3.05e-04 | 245 | 139 | 8 | int:NPAS1 | |
| Interaction | USF1 interactions | 3.06e-04 | 85 | 139 | 5 | int:USF1 | |
| Interaction | STK32C interactions | 3.41e-04 | 87 | 139 | 5 | int:STK32C | |
| Interaction | BRCA1 interactions | MMS22L CAD SLF1 ORC3 CIP2A ANKRD26 FANCA ANKRD44 NF1 MDN1 PLAA SLF2 EIF4G1 KIF2A PRKDC ATM BRAT1 DYNC1H1 XRCC6 KIF2C | 3.64e-04 | 1249 | 139 | 20 | int:BRCA1 |
| Interaction | CIT interactions | RANBP2 CAD ORC3 RALGAPA2 ZZEF1 TRRAP WDR3 NBAS LRRC31 MROH2B CCDC62 RGPD3 EIF4G1 CDK5RAP2 MAIP1 KIF2A PRKDC ARHGAP11B DYNC1H1 XRCC6 KIF2C SYMPK | 3.81e-04 | 1450 | 139 | 22 | int:CIT |
| Cytoband | 2q12.3 | 2.07e-05 | 17 | 146 | 3 | 2q12.3 | |
| Cytoband | 7q35 | 2.95e-05 | 55 | 146 | 4 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 6.07e-05 | 66 | 146 | 4 | chr7q35 | |
| Cytoband | 2p24 | 6.49e-04 | 12 | 146 | 2 | 2p24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 8.99e-04 | 59 | 146 | 3 | chr2q13 | |
| Cytoband | Yp11.3 | 1.17e-03 | 16 | 146 | 2 | Yp11.3 | |
| Cytoband | 15q15.2 | 1.17e-03 | 16 | 146 | 2 | 15q15.2 | |
| Cytoband | 2q13 | 1.36e-03 | 68 | 146 | 3 | 2q13 | |
| Cytoband | 15q13.2 | 2.03e-03 | 21 | 146 | 2 | 15q13.2 | |
| Cytoband | Xp22.3 | 2.43e-03 | 23 | 146 | 2 | Xp22.3 | |
| Cytoband | 13q12 | 2.65e-03 | 24 | 146 | 2 | 13q12 | |
| Cytoband | 3q27 | 2.87e-03 | 25 | 146 | 2 | 3q27 | |
| GeneFamily | CTAGE family | 4.71e-13 | 15 | 93 | 7 | 907 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.64e-09 | 115 | 93 | 9 | 769 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 9.07e-05 | 46 | 93 | 4 | 622 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.26e-04 | 50 | 93 | 4 | 1293 | |
| GeneFamily | Argonaute/PIWI family | 7.18e-04 | 8 | 93 | 2 | 408 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 3.00e-03 | 16 | 93 | 2 | 14 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 5.16e-03 | 21 | 93 | 2 | 680 | |
| Coexpression | TERAO_AOX4_TARGETS_HG_UP | 8.06e-07 | 32 | 143 | 5 | MM922 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 MYO10 ARHGAP11A ZZEF1 TRRAP PAIP1 NBAS ASAP2 IGF2R MDN1 MIA2 ST3GAL5 SACS KIF2A IL1R1 CLEC16A KLC1 | 4.54e-06 | 856 | 143 | 17 | M4500 |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP | 1.47e-05 | 200 | 143 | 8 | M6555 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | ZYG11A MMS22L PAMR1 POLE2 TLR6 ARHGAP11A ADCY3 FANCA CCNG2 SACS ASPM KIF2A KIF2C | 2.14e-05 | 588 | 143 | 13 | M38992 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 3.07e-05 | 33 | 143 | 4 | MM477 | |
| Coexpression | LEE_BMP2_TARGETS_DN | MMS22L CAD SLF1 CIP2A POLE2 ANKRD26 SHQ1 FANCA WDR3 MDN1 PLAA SACS EIF2B3 DAAM2 IL1R1 XRCC6 | 3.60e-05 | 904 | 143 | 16 | M2325 |
| Coexpression | LEE_BMP2_TARGETS_DN | MMS22L CAD SLF1 CIP2A POLE2 ANKRD26 SHQ1 FANCA WDR3 MDN1 PLAA SACS EIF2B3 DAAM2 IL1R1 XRCC6 | 4.55e-05 | 922 | 143 | 16 | MM1068 |
| Coexpression | MATZUK_SPERMATOCYTE | 4.70e-05 | 72 | 143 | 5 | M1831 | |
| Coexpression | MATZUK_SPERMATOCYTE | 5.02e-05 | 73 | 143 | 5 | MM1234 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL | MMS22L SLF1 ORC3 CIP2A POLE2 TTI2 ANKRD26 FAM98B ARHGAP11A DNTTIP1 FANCA PLAA EIF2B3 EIF4G1 ASPM CDK5RAP2 ANKRD36 PRKDC BRAT1 KIF2C | 5.26e-05 | 1363 | 143 | 20 | M45782 |
| Coexpression | BRACHAT_RESPONSE_TO_METHOTREXATE_DN | 5.43e-05 | 38 | 143 | 4 | MM1161 | |
| Coexpression | MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN | 6.10e-05 | 76 | 143 | 5 | M9193 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | RANBP2 CAD ORC3 CIP2A POLE2 ARHGAP11A PAIP1 WDR3 FRMD4A NF1 SACS ASPM KCNMA1 PIGW PRKDC ARHGAP11B PLXNA1 EDRF1 XRCC6 KIF2C | 8.14e-05 | 1407 | 143 | 20 | M14427 |
| Coexpression | FISCHER_DREAM_TARGETS | MMS22L CAD SLF1 ORC3 CIP2A POLE2 ARHGAP11A FANCA SLF2 ASPM PIGW CDK5RAP2 KIF2A PRKDC ARHGAP11B KIF2C | 8.16e-05 | 969 | 143 | 16 | M149 |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 8.89e-05 | 43 | 143 | 4 | MM3857 | |
| Coexpression | RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP | 1.11e-04 | 341 | 143 | 9 | M12636 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN | 1.14e-04 | 199 | 143 | 7 | M9897 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP | 1.14e-04 | 199 | 143 | 7 | M4260 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP | 1.14e-04 | 199 | 143 | 7 | M4266 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP | 1.18e-04 | 200 | 143 | 7 | M9909 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN | 1.18e-04 | 200 | 143 | 7 | M5292 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP | 1.18e-04 | 200 | 143 | 7 | M5185 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | ZYG11A MMS22L CAD CIP2A ANKRD26 RANBP17 MDN1 PLAA EIF2B3 CCDC138 ATM EDRF1 XRCC6 KIF2C | 1.13e-07 | 361 | 139 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | ZYG11A MMS22L CAD CIP2A TEX15 CHUK RANBP17 MDN1 EIF2B3 CCDC138 PRKDC ATM EDRF1 XRCC6 | 2.47e-07 | 385 | 139 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ZYG11A MMS22L CAD CIP2A ANKRD26 TEX15 RALGAPA2 LYST CHUK RANBP17 MDN1 PLAA CCDC62 EIF2B3 CCDC138 PRKDC ATM EDRF1 XRCC6 KIF2C | 4.02e-07 | 820 | 139 | 20 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 7.22e-07 | 152 | 139 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | ZYG11A MMS22L CAD CIP2A RANBP17 MDN1 PLAA EIF2B3 ATM XRCC6 KIF2C | 1.47e-06 | 266 | 139 | 11 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | ZYG11A CAD CIP2A RANBP17 WDR3 MDN1 PLAA EIF2B3 ATM XRCC6 KIF2C | 1.25e-05 | 333 | 139 | 11 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | ZYG11A CAD TEX15 SHQ1 RANBP17 MDN1 CCDC138 PRKDC ATM XRCC6 KIF2C | 6.11e-05 | 396 | 139 | 11 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | ZYG11A MMS22L CAD CIP2A TEX15 SHQ1 RANBP17 WDR3 MDN1 PLAA EIF2B3 CCDC138 PRKDC ATM XRCC6 KIF2C | 6.62e-05 | 795 | 139 | 16 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 6.68e-05 | 105 | 139 | 6 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | ZYG11A MMS22L CAD CIP2A TEX15 RANBP17 MDN1 PRKDC ATM XRCC6 KIF2C | 7.64e-05 | 406 | 139 | 11 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ZYG11A CAD CIP2A TEX15 SHQ1 RANBP17 WDR3 TBC1D32 MDN1 PLAA EIF2B3 CCDC138 PRKDC ATM XRCC6 KIF2C | 8.24e-05 | 810 | 139 | 16 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.59e-08 | 193 | 146 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-07 | 190 | 146 | 8 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.24e-07 | 190 | 146 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.73e-07 | 195 | 146 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 168 | 146 | 7 | b9db0b1e4fe54a1fe79530d15d206155a1bfac39 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.22e-06 | 180 | 146 | 7 | 42f48e646fc6e72ad3cce72409ace3a0b64020a2 | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.66e-06 | 185 | 146 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.28e-06 | 191 | 146 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.40e-06 | 192 | 146 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-06 | 194 | 146 | 7 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.89e-06 | 196 | 146 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.02e-06 | 197 | 146 | 7 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.30e-06 | 199 | 146 | 7 | c9d15c84b9f8c87b4ea0008be7d5efc5f45efd1a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.30e-06 | 199 | 146 | 7 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.30e-06 | 199 | 146 | 7 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.30e-06 | 199 | 146 | 7 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-05 | 163 | 146 | 6 | ce07bc424ef99c547588b07f5c8b39ff0773ca9b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 168 | 146 | 6 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.02e-05 | 169 | 146 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-05 | 169 | 146 | 6 | e68e6c24606fd46eca6f86bb63fa86ea17879ae2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.02e-05 | 169 | 146 | 6 | 481e611b5fface58f1630f206c0b04fb54e24011 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 173 | 146 | 6 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 2.38e-05 | 174 | 146 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-05 | 175 | 146 | 6 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 2.54e-05 | 176 | 146 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.62e-05 | 177 | 146 | 6 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.62e-05 | 177 | 146 | 6 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-05 | 179 | 146 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 181 | 146 | 6 | b203b616584cdbd0bbb0e382b2916d0bd49d3526 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 181 | 146 | 6 | c748c16fd20d1949d33ff6290dc9d9016c4dc86c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-05 | 185 | 146 | 6 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.35e-05 | 185 | 146 | 6 | a3cd0511fa7cf317c3fcb7082fa785bbf51c5cef | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 186 | 146 | 6 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 186 | 146 | 6 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.56e-05 | 187 | 146 | 6 | 4527d6426f2c4397e47f12439a13a8c14fd2aab2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.56e-05 | 187 | 146 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.56e-05 | 187 | 146 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.67e-05 | 188 | 146 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 189 | 146 | 6 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 189 | 146 | 6 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.89e-05 | 190 | 146 | 6 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.01e-05 | 191 | 146 | 6 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.25e-05 | 193 | 146 | 6 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.25e-05 | 193 | 146 | 6 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 4.37e-05 | 194 | 146 | 6 | a8ae49157ca3f9e8b3f1750a995aee012dc859b6 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.37e-05 | 194 | 146 | 6 | 30f683725cb13ae32ef6846618801ec78e12397d | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.50e-05 | 195 | 146 | 6 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.50e-05 | 195 | 146 | 6 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.50e-05 | 195 | 146 | 6 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 4.50e-05 | 195 | 146 | 6 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.50e-05 | 195 | 146 | 6 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.50e-05 | 195 | 146 | 6 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.63e-05 | 196 | 146 | 6 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.63e-05 | 196 | 146 | 6 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.76e-05 | 197 | 146 | 6 | 4b13335a43b9d6abc8e542e72440da7feb82fbe6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.76e-05 | 197 | 146 | 6 | 21861d8b389fafbdb7c3499684c9b6deee3dbd5e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.76e-05 | 197 | 146 | 6 | ffb004c37cdd26cb7cdcd80f769a2eded65416dc | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.90e-05 | 198 | 146 | 6 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | distal-2-Hematologic-Proliferating_NK/T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.90e-05 | 198 | 146 | 6 | a5fd710df5669c95fc5b5ef6e5cfafe6687c7b72 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.90e-05 | 198 | 146 | 6 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.90e-05 | 198 | 146 | 6 | 50f236ab7ef6f00721f6cd714e3eee183077beeb | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.90e-05 | 198 | 146 | 6 | dc0c6189ff9dd76675f63acf1cbc7dda60e75f3f | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.90e-05 | 198 | 146 | 6 | 7225a6194c52b01c581e58d3cda107c4af96dc4f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.90e-05 | 198 | 146 | 6 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | cycling_basal_cell|World / shred by cell class for turbinate | 4.90e-05 | 198 | 146 | 6 | e86c1224f5b0890a50a25257628e90c790aae7cd | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.90e-05 | 198 | 146 | 6 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.03e-05 | 199 | 146 | 6 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-05 | 199 | 146 | 6 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.03e-05 | 199 | 146 | 6 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.03e-05 | 199 | 146 | 6 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.03e-05 | 199 | 146 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 5.03e-05 | 199 | 146 | 6 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.03e-05 | 199 | 146 | 6 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.03e-05 | 199 | 146 | 6 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 5.03e-05 | 199 | 146 | 6 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.03e-05 | 199 | 146 | 6 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.03e-05 | 199 | 146 | 6 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.03e-05 | 199 | 146 | 6 | 616c04b0605907fb218263f2164c36cb2fa26b87 | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 5.18e-05 | 200 | 146 | 6 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.18e-05 | 200 | 146 | 6 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors_nGenesUnder4k|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | 8223d2c9b9e05b1d26e3de1bc0226d175af2e7b2 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-05 | 200 | 146 | 6 | 548a0f486ab8745da107f2815914dbf873a6e3c8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_ventral_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | 9359faa749f41aaef70b4874f20b4eed2dc12cc2 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.18e-05 | 200 | 146 | 6 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.18e-05 | 200 | 146 | 6 | 562309f9ca4a73cea5ed1d85b516891545f3ae5f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-05 | 200 | 146 | 6 | 43571c9284d4e41402a2d1eefc1efe2ce8476d4a | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 5.18e-05 | 200 | 146 | 6 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 5.18e-05 | 200 | 146 | 6 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.18e-05 | 200 | 146 | 6 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | 0bba93f1271dac704dddcdea8cb0f84a7ac6f42a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells-Neuroepithelial_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | 55501f83409e0174c756a13ad8077f5b59975e27 | |
| ToppCell | (3)_MNP-(3)_DC_Monocyte_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.18e-05 | 200 | 146 | 6 | d94fe9bd6ee7c1fed14666f24de41bda014e299b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Stem_cells|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | b9aad527d3ad5bc701e93fa2afdebf695b2a74bb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Stem_cells-Neuroepithelial_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | c9479452ab8c51139522383f745f02171ebbd7e2 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | 8f9e76048ae6f45218a09a95a2c4b31e8a8937b2 | |
| ToppCell | LPS_only-Endothelial-Epi-like|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.98e-05 | 126 | 146 | 5 | 4c598f7bae09aca7a4ecce63dfd6890b26468c73 | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.80e-06 | 196 | 141 | 9 | 5411_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 3.80e-06 | 196 | 141 | 9 | 2936_DN | |
| Drug | NSC-85245 | 1.14e-05 | 23 | 141 | 4 | CID000257281 | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 1.69e-05 | 180 | 141 | 8 | 1076_DN | |
| Drug | DO 897/99; Down 200; 8.2uM; HL60; HG-U133A | 2.90e-05 | 194 | 141 | 8 | 1728_DN | |
| Drug | Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 3.12e-05 | 196 | 141 | 8 | 3534_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.12e-05 | 196 | 141 | 8 | 3471_DN | |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 3933_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.23e-05 | 197 | 141 | 8 | 1541_DN | |
| Drug | Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.35e-05 | 198 | 141 | 8 | 5485_DN | |
| Drug | Guanadrel sulfate [22195-34-2]; Down 200; 7.6uM; PC3; HT_HG-U133A | 3.47e-05 | 199 | 141 | 8 | 3698_DN | |
| Drug | Ro 8-8717 | 3.81e-05 | 2 | 141 | 2 | CID006438148 | |
| Drug | 6-fluorocholesterol | 3.81e-05 | 2 | 141 | 2 | CID000135206 | |
| Drug | 25-fluorocholesterol | 3.81e-05 | 2 | 141 | 2 | CID006454807 | |
| Drug | Tamibarotene | 3.81e-05 | 2 | 141 | 2 | DB04942 | |
| Drug | 7-tricosene | 3.81e-05 | 2 | 141 | 2 | CID006365493 | |
| Disease | Intellectual Disability | SPR TTI2 TRRAP LINS1 FRY NF1 AGO1 ST3GAL5 SACS PACS2 LSS DYNC1H1 | 9.27e-07 | 447 | 133 | 12 | C3714756 |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 1.20e-04 | 4 | 133 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 1.20e-04 | 4 | 133 | 2 | C0751925 | |
| Disease | Sciatic Neuropathy | 1.20e-04 | 4 | 133 | 2 | C0149940 | |
| Disease | Lesion of Sciatic Nerve | 1.20e-04 | 4 | 133 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 1.20e-04 | 4 | 133 | 2 | C0242013 | |
| Disease | spermatogenic failure (is_implicated_in) | 1.48e-04 | 23 | 133 | 3 | DOID:0111910 (is_implicated_in) | |
| Disease | Microcephaly | 2.43e-04 | 67 | 133 | 4 | C0025958 | |
| Disease | Global developmental delay | 3.50e-04 | 133 | 133 | 5 | C0557874 | |
| Disease | Colorectal Carcinoma | SELENOP CAD RARB SETD4 NF1 SH3TC1 SACS CCDC62 EIF4G1 FLCN EDRF1 | 3.50e-04 | 702 | 133 | 11 | C0009402 |
| Disease | Obesity, Morbid | 4.17e-04 | 7 | 133 | 2 | C0028756 | |
| Disease | Profound Mental Retardation | 4.28e-04 | 139 | 133 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 4.28e-04 | 139 | 133 | 5 | C0025363 | |
| Disease | Mental deficiency | 4.28e-04 | 139 | 133 | 5 | C0917816 | |
| Disease | Lung diseases | 4.35e-04 | 78 | 133 | 4 | C0024115 | |
| Disease | microcephaly (is_implicated_in) | 5.55e-04 | 8 | 133 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 6.02e-04 | 85 | 133 | 4 | DOID:9744 (is_implicated_in) | |
| Disease | hypospadias | 7.27e-04 | 39 | 133 | 3 | EFO_0004209 | |
| Disease | Adenocarcinoma of large intestine | 9.51e-04 | 96 | 133 | 4 | C1319315 | |
| Disease | Adenoid Cystic Carcinoma | 1.11e-03 | 100 | 133 | 4 | C0010606 | |
| Disease | dimethylglycine measurement | 1.18e-03 | 46 | 133 | 3 | EFO_0010476 | |
| Disease | Autistic Disorder | 1.22e-03 | 261 | 133 | 6 | C0004352 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.52e-03 | 13 | 133 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | Skin Abnormalities | 1.52e-03 | 13 | 133 | 2 | C0037268 | |
| Disease | dystonia (is_implicated_in) | 1.77e-03 | 14 | 133 | 2 | DOID:543 (is_implicated_in) | |
| Disease | Malformations of Cortical Development | 1.77e-03 | 14 | 133 | 2 | C1955869 | |
| Disease | Cortical Dysplasia | 1.77e-03 | 14 | 133 | 2 | C0431380 | |
| Disease | leukemia | 1.98e-03 | 55 | 133 | 3 | C0023418 | |
| Disease | Autosomal recessive primary microcephaly | 2.04e-03 | 15 | 133 | 2 | cv:C3711387 | |
| Disease | abdominal fat cell number | 2.08e-03 | 198 | 133 | 5 | EFO_0021534 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 2.25e-03 | 295 | 133 | 6 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | colon cancer (is_marker_for) | 2.42e-03 | 59 | 133 | 3 | DOID:219 (is_marker_for) | |
| Disease | Adenocarcinoma of lung (disorder) | 2.47e-03 | 206 | 133 | 5 | C0152013 | |
| Disease | theta wave measurement | 2.62e-03 | 17 | 133 | 2 | EFO_0006873 | |
| Disease | C-reactive protein measurement | MMS22L CAD RARB ORC3 SETD4 ZZEF1 ADCY3 JMY FANCA RANBP17 ANKRD44 PPP1R37 IL1R1 | 3.20e-03 | 1206 | 133 | 13 | EFO_0004458 |
| Disease | facial asymmetry measurement | 3.28e-03 | 19 | 133 | 2 | EFO_0009751 | |
| Disease | Adenocarcinoma of prostate | 3.63e-03 | 20 | 133 | 2 | C0007112 | |
| Disease | Autosomal Recessive Primary Microcephaly | 4.39e-03 | 22 | 133 | 2 | C3711387 | |
| Disease | lymphocyte count, response to vaccine | 4.39e-03 | 22 | 133 | 2 | EFO_0004587, EFO_0004645 | |
| Disease | Primary microcephaly | 4.39e-03 | 22 | 133 | 2 | C0431350 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AQKSCDLLLFLRDKI | 716 | Q6PJG6 | |
| KLRSLLAEGLVLLDC | 131 | Q96Q91 | |
| EKIKGLLLDCNVALT | 276 | Q8IZ81 | |
| ALSGLIEEKCKLLEK | 51 | Q96RT6 | |
| TLSGLIEEKCKLLEK | 81 | Q8IX94 | |
| TLSGLIEEKCKLLEK | 81 | Q86UF2 | |
| TLSGLIEEKCKLLEK | 81 | P0CG41 | |
| TLSGLIEEKCKLLEK | 81 | A4FU28 | |
| TLSGLIEEKCKLLEK | 81 | A4D2H0 | |
| IRLKQEKSCLHDELL | 241 | Q6P9F0 | |
| NDLDKLLLCLKISDK | 926 | Q96NH3 | |
| ELLAIRDACIKLEKD | 681 | Q9UL18 | |
| LALCLLNLEVETLKS | 206 | Q16589 | |
| EGSESLKSLCLKLLL | 151 | Q5T2E6 | |
| QALKDSLKTLADIIC | 336 | P56282 | |
| LKHEILELEKELCSL | 1421 | A6QL64 | |
| ELLLDICVSLKLLKV | 61 | P46597 | |
| ERLLELKKNHCELLT | 736 | Q9UPS8 | |
| KGTLKLLAENERLLC | 386 | Q8IWY9 | |
| ALSKFTLKKLLLLVC | 881 | Q8IZT6 | |
| LKLSLKSKEALIQCL | 226 | Q96SN8 | |
| ALELFLESLLKKACQ | 41 | Q14919 | |
| LLIACEIILFLTKDE | 36 | Q8NCQ3 | |
| KDVLVLACSLLKEVF | 186 | Q9H2T7 | |
| LVLKIAELLCKNDVT | 96 | P49792 | |
| TLALELLKDEGLLSC | 276 | Q9HBI0 | |
| DQITLLKAACLDILI | 256 | P10276 | |
| DQITLLKAACLDILI | 256 | P10826 | |
| LVLKIAELLCKNDVT | 96 | Q99666 | |
| LVLKIAELLCKNDVT | 96 | O14715 | |
| EKNKAILLLSCLLAD | 151 | Q3KRB8 | |
| CIILLSKLKLSNEEI | 681 | Q86T65 | |
| SKVLCVLKDLLVAAI | 146 | Q08AI8 | |
| LLKALLEIASCLEKA | 196 | P14902 | |
| TALLARKECLKFLIK | 1656 | Q9NU22 | |
| KILLESAKVDSKLIC | 121 | Q8NG48 | |
| SKLLSQCKFDLLEEL | 156 | Q8WWC4 | |
| LARVKIESADACLIL | 476 | Q12791 | |
| KCEELLLTAQLESIK | 546 | Q8N9B5 | |
| IRKCLEKLDTDISLI | 516 | Q8IXH7 | |
| LLKACGSRLTEKLLE | 261 | Q8NFG4 | |
| IRTLLLNCLKLLDKS | 481 | Q3B7T1 | |
| KAQKLLFRIIDCLLL | 961 | Q6ZRQ5 | |
| EKLSCDADLVILLSL | 1161 | Q76N89 | |
| ELDLKIAIKSCRLEL | 36 | O15111 | |
| LLTACKLKVFDLLKD | 301 | O95671 | |
| CLKLLLRGKASIEIA | 636 | O43150 | |
| ALCLFTLRAIKEKIK | 356 | Q9UIW2 | |
| SLLLICKSSLFLKLV | 526 | P31512 | |
| LGELRKLDLSCNKDL | 281 | Q6UY01 | |
| CTAEALKAVLLLQEK | 456 | P48449 | |
| ECLDLIEKKLGLLAL | 491 | Q9HD67 | |
| DLTKLLQEKSSLLCL | 916 | Q9NX02 | |
| CALLILDKIQDESLI | 921 | Q8N8A2 | |
| EILAVLKLACADISI | 181 | Q9NQN1 | |
| LCSLTLKKLVVFKEL | 41 | Q86VP3 | |
| TDKKFIVSLLLCLLD | 1251 | Q2PPJ7 | |
| CDQELLSLLLDAKLL | 2286 | A2RRP1 | |
| LSLLLDAKLLVKCVS | 2291 | A2RRP1 | |
| LKLDDLSTCNDLIAK | 311 | Q969R2 | |
| LKLAKLLLCGTELVT | 81 | Q96MC2 | |
| LICAVKLLKLTGSVL | 316 | Q9H074 | |
| LSCSKNEKELEELLL | 666 | O75864 | |
| INKSLLALKECIRAL | 481 | O00139 | |
| LGNLLLDKCLSEKAV | 316 | Q8NH40 | |
| LVLKIAELLCKNDVT | 96 | A6NKT7 | |
| LEELKKLCLREAELT | 406 | Q9P2Q2 | |
| KLKTDVLVLSCDLIT | 96 | Q9NR50 | |
| CIKDILTKHLVELSI | 2246 | Q13315 | |
| ILAEEAVLKQKCLLT | 716 | Q9HCM4 | |
| LCLDLKTEEGKTLFL | 516 | Q96M89 | |
| SLRKLLESCKDLSLL | 576 | Q9UKA2 | |
| LLLESNSAKDLACLI | 471 | Q5SYB0 | |
| LKKLDCEREELLVFL | 1246 | O15360 | |
| LKHKDIITSLCEDIL | 201 | Q9NSG2 | |
| VLDIILFVLCKKGLL | 116 | O60266 | |
| EDCLKLLLFLSTELQ | 111 | Q52LJ0 | |
| KAASLLLEILGLLCK | 1371 | Q04637 | |
| LLSLLEKVCKFDVTL | 261 | Q99698 | |
| CTKILLLGILKIIES | 1371 | Q99698 | |
| ESLCQAALGLILKEK | 506 | Q96RQ3 | |
| LKKEITNCLKLLESL | 246 | Q12912 | |
| AVKLALESICLLLGE | 3316 | Q14204 | |
| CGLLDKLKFSVLELQ | 2766 | Q5TBA9 | |
| QISEDLKTKVLVLCL | 441 | O60645 | |
| ACSLTLIDLKELKIE | 51 | A0A1B0GVD1 | |
| EELVKELEICLKAAL | 691 | Q7Z3Z3 | |
| LKTTSCLKLVLKDIE | 986 | Q9NZJ4 | |
| IALLISSLEADKCKE | 11 | P14778 | |
| INKSLLALKECIRAL | 516 | Q99661 | |
| LDQLLSCLKTSLKVL | 191 | H0Y7S4 | |
| INKSLLALKECILAL | 471 | Q8N4N8 | |
| LQSLLETLKCLKKDD | 46 | Q07866 | |
| LLDADIAILKLLDKA | 556 | Q6UXH9 | |
| CKEHLTTVLDKLLLT | 281 | Q9UBD5 | |
| LTKCLESTKLLADLK | 16 | Q96PC5 | |
| KDLLDLHKSLVCTAL | 251 | O43427 | |
| ALTCCLLALLLYKKE | 2316 | P11717 | |
| DLLDCLPEIEKATLK | 941 | Q5VT97 | |
| LVLKIAELLCKNDVT | 96 | Q7Z3J3 | |
| EKNKATLLLSCLLAD | 151 | Q6P4F7 | |
| TCALELLKDVKETLL | 106 | B4DZS4 | |
| TCALELLKDVKENRL | 21 | Q5H9J9 | |
| LLTALKLLCLEAEKF | 341 | Q9NVD3 | |
| KLIEKILLNISADCL | 751 | Q86V20 | |
| LQLGKSAVLKCLLDI | 351 | Q6PI26 | |
| SLLLKDILKCTLLVF | 61 | Q9UNP4 | |
| ELQLSLACKVADKVL | 1011 | Q8TE82 | |
| EVATLCKLDILKSLD | 251 | Q8TF30 | |
| CLSLVIISKLLDEKH | 1016 | Q8IX21 | |
| LLEAQKRLEKLTTLC | 781 | Q9P2P6 | |
| VVCESLKALKKILEL | 1361 | Q7Z745 | |
| LCILQASKLEDLRVK | 61 | P49908 | |
| SHIKDLIKVACFLLL | 331 | Q7Z7B1 | |
| VLLCKLDLDKRLSQE | 331 | Q8TED9 | |
| LCKLAADVILKTLDL | 471 | Q8TCG1 | |
| KIRLATLELSCLLLK | 556 | Q2KHT3 | |
| LCILISKALINTVLK | 301 | P98196 | |
| ECKVAVALTLLRFKL | 461 | Q86W10 | |
| HELCKKDELLRIVSI | 166 | O60296 | |
| LFSALLIKCLEKEVA | 381 | P12956 | |
| KDLLFRDDTVCLAKL | 646 | P02787 | |
| CLEELLSSRDLLAKL | 281 | Q99797 | |
| CLDLKLEELKSFVLP | 286 | Q9H147 | |
| VSCRLVVLLKALLKL | 421 | Q6NXR4 | |
| VVLLKALLKLICDVA | 426 | Q6NXR4 | |
| KSALLQEATDCLILL | 451 | Q6NXR4 | |
| LKDIETACKLLNITA | 131 | O95238 | |
| LVDCKVSAQKLLSLL | 231 | P35270 | |
| SLTIAEFKCKLELLV | 31 | Q99426 | |
| DDLILLEKILSLICN | 571 | Q9Y263 | |
| LSQLIILDTLEKCLA | 81 | P21359 | |
| EVVSLCKELIHLALK | 416 | O95427 | |
| EALVKLLLKLDCTFI | 21 | Q9BQI6 | |
| LIIDIKCTKLFVEAL | 1426 | P27708 | |
| IEEACKRDIELLLKL | 96 | Q92797 | |
| EKCSTLVKLETLILQ | 371 | Q9Y2C9 | |
| ILEESLCELVAKQLK | 2336 | P78527 | |
| LLLDLSCEISLLKSE | 201 | Q9BS86 | |
| LAKECIEKSLLLLKF | 1416 | O43149 | |
| KLLLAEALLEQCLKE | 66 | Q9ULT0 | |
| LCLHLKAEALIKLSD | 351 | Q6PGP7 | |
| DLTLRCTDHLEILKK | 2006 | Q9BXT5 | |
| LKEILECSHLLTVIK | 381 | Q7Z2W7 | |
| QKLLAVSLLDCTVKI | 561 | Q9UNX4 | |
| KDLLKAERCLLETLA | 786 | Q6ZXV5 | |
| ALLCKEELKQLLLAE | 26 | Q6XPR3 | |
| RLLSEVTCLLFKALK | 421 | Q6WRX3 | |
| KLLLNLVDCIRSKSE | 421 | Q9Y4A5 | |
| VLKKILDSLISDLSC | 166 | Q6X784 | |
| CIDLIEAKLGILDLL | 496 | Q9ULV0 | |
| NKEVEDLSATLLCKL | 591 | Q5VU43 |